Paper39558302
Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg).
Krauss E and 18 others. BMC Pulm Med, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg). Papers, record 39558302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39558302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg).
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Diseases, Interstitial | Major topic |
| Registries | Major topic |
| Biological Specimen Banks | Major topic |
| Humans | |
| Europe | |
| Adult | |
| Child | |
| Biomarkers | |
| Quality of Life | |
| Research Design |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02951416 | Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank | Derived from the trial | Yes |
Source ClinicalTrials.gov
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33023996 | Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. | Thorax | 2021 | https://conductscience.org/library/papers/33023996 | PubMed |
| 2 | 37872563 | Walking the path of treatable traits in interstitial lung diseases. | Respir Res | 2023 | https://conductscience.org/library/papers/37872563 | PubMed |
| 3 | 12668799 | Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). | Thorax | 2003 | https://conductscience.org/library/papers/12668799 | PubMed |
| 4 | 32756496 | Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg). | J Clin Med | 2020 | https://conductscience.org/library/papers/32756496 | PubMed |
| 5 | 21479777 | Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). | Qual Life Res | 2011 | https://conductscience.org/library/papers/21479777 | PubMed |
| 6 | 18728209 | International registry for idiopathic pulmonary fibrosis. | Thorax | 2008 | https://conductscience.org/library/papers/18728209 | PubMed |
| 7 | 33266405 | Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg). | J Clin Med | 2020 | https://conductscience.org/library/papers/33266405 | PubMed |
| 8 | 36206780 | Home monitoring in interstitial lung diseases. | Lancet Respir Med | 2023 | https://conductscience.org/library/papers/36206780 | PubMed |
| 9 | 33080140 | The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality. | Am J Respir Crit Care Med | 2021 | https://conductscience.org/library/papers/33080140 | PubMed |
| 10 | 25478169 | Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry. | BMJ Open Respir Res | 2014 | https://conductscience.org/library/papers/25478169 | PubMed |
| 11 | 36549714 | European Respiratory Society statement on familial pulmonary fibrosis. | Eur Respir J | 2023 | https://conductscience.org/library/papers/36549714 | PubMed |
| 12 | 37948041 | Emerging Treatments for Childhood Interstitial Lung Disease. | Paediatr Drugs | 2024 | https://conductscience.org/library/papers/37948041 | PubMed |
| 13 | 30072107 | Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials. | Lancet Respir Med | 2018 | https://conductscience.org/library/papers/30072107 | PubMed |
| 14 | 29408012 | Biomarkers in idiopathic pulmonary fibrosis. | Matrix Biol | 2018 | https://conductscience.org/library/papers/29408012 | PubMed |
| 15 | 34024399 | Interstitial Lung Disease in 2020: A History of Progress. | Clin Chest Med | 2021 | https://conductscience.org/library/papers/34024399 | PubMed |
| 16 | 30091679 | The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease. | Ther Adv Respir Dis | 2018 | https://conductscience.org/library/papers/30091679 | PubMed |
| 17 | 33419890 | Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. | Eur Respir J | 2021 | https://conductscience.org/library/papers/33419890 | PubMed |
| 18 | 32437843 | Diagnostic approach of fibrosing interstitial lung diseases of unknown origin. | Presse Med | 2020 | https://conductscience.org/library/papers/32437843 | PubMed |
| 19 | 29471816 | Idiopathic pulmonary fibrosis: pathogenesis and management. | Respir Res | 2018 | https://conductscience.org/library/papers/29471816 | PubMed |
| 20 | 31729868 | Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors. | Chem Rev | 2019 | https://conductscience.org/library/papers/31729868 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42715138 | Multidimensional Clinical Deterioration in Interstitial Lung Disease: Longitudinal Concordance of Frailty, Patient-Reported Outcomes, and Lung Function in a Multinational European Registry Cohort Study. | Respiration | 2026 | https://conductscience.org/library/papers/42715138 | PubMed |
| 42681624 | Post-transplant trajectories of the CRP-to-albumin ratio identify a late-emerging high-risk phenotype in interstitial lung disease. | BMC Pulm Med | 2026 | https://conductscience.org/library/papers/42681624 | PubMed |
| 42519218 | Peri-transplant frailty changes impact survival in interstitial lung diseases. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42519218 | PubMed |
| 42513486 | Beyond Diffusion Capacity: Continuous Exercise Oximetry Reveals Phenotype-Related Cardiopulmonary Signals in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis-A eurILDreg Pilot Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42513486 | PubMed |
| 42113746 | Sex-Dependent Integration of Symptoms and Functional Vulnerability in Interstitial Lung Disease: eurILDreg Study. | Respiration | 2026 | https://conductscience.org/library/papers/42113746 | PubMed |
| 41464600 | The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden. | J Clin Med | 2025 | https://conductscience.org/library/papers/41464600 | PubMed |
| 41303225 | Treatable Traits in Pediatric Interstitial Lung Diseases: Bridging the Gap to Tailored Therapeutics. | J Clin Med | 2025 | https://conductscience.org/library/papers/41303225 | PubMed |
| 41156222 | Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry. | J Clin Med | 2025 | https://conductscience.org/library/papers/41156222 | PubMed |
| 41153750 | Beyond Labels: Can Biomarkers and Treatable Traits Revolutionize Interstitial Lung Disease Care? | Biomedicines | 2025 | https://conductscience.org/library/papers/41153750 | PubMed |
| 41010625 | Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010625 | PubMed |
| 40365093 | An update on diagnosis and treatments of childhood interstitial lung diseases. | Breathe (Sheff) | 2025 | https://conductscience.org/library/papers/40365093 | PubMed |
| 39879227 | European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD). | PLoS One | 2025 | https://conductscience.org/library/papers/39879227 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39558302
GET https://conductscience.org/api/papers/v1/39558302/references?page=2